Contineum Therapeutics, Inc.
USD14.23
+0.22 (+1.57%)
CEO
Carmine N. Stengone
IPO Date
2024-04-04
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$13.75
Prev. Close
$14.01
Day Low
$13.38
Day High
$14.52
52W Low
$4.67
52W High
$16.91
Market Cap
$0.53B
Volume
0.13M
| 25 |
| $16.00 |
| 10 Jul 2026 | Lorrain Daniel S. | Chief Scientific Officer | M-Exempt | Acquired | 25 | $1.01 |
| 10 Jul 2026 | Lorrain Daniel S. | Chief Scientific Officer | M-Exempt | Disposed | 1,015 | $1.01 |
| 10 Jul 2026 | Lorrain Daniel S. | Chief Scientific Officer | M-Exempt | Disposed | 25 | $1.01 |
| 8 Jul 2026 | Stengone Carmine N. | director, officer: CEO and President | M-Exempt | Acquired | 2,500 | $1.01 |
| 8 Jul 2026 | Stengone Carmine N. | director, officer: CEO and President | S-Sale | Disposed | 2,500 | $16.00 |
| 8 Jul 2026 | Stengone Carmine N. | director, officer: CEO and President | M-Exempt | Disposed | 2,500 | $1.01 |
| 2 Jul 2026 | Lorrain Daniel S. | Chief Scientific Officer | M-Exempt | Acquired | 28,826 | $1.01 |
| 2 Jul 2026 | Lorrain Daniel S. | Chief Scientific Officer | S-Sale | Disposed | 28,826 | $16.04 |